Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ELCC 2021 | Roy Castle Lung Cancer: genomics and novel risk models

John Field, MA, PhD, BDS, FRCPath, University of Liverpool, Liverpool, UK, shares an update on Roy Castle Lung Cancer research projects, including the Liverpool Lung Project which has developed and expanded the LLP risk model. Prof. Field outlines the use of the LLP risk model as well as genome-wide association studies (GWAS) looking at susceptibility genes, the discovery of molecular biomarkers, radiomics and novel risk models. This video was recorded at the virtual European Lung Cancer Congress (ELCC) 2021.


Prof. John Field, MA, PhD, BDS, FRCPath, has participated in a speaker’s bureau with AstraZeneca; has participated in advisory boards for Epigenomics, NUCLEIX Ltd., AstraZeneca and iDNA; and has received grant support from Janssen Research & Development, LLC.